NYSE · CTEV
Claritev Corporation
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
Price chart by TradingView
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarEarnings announcement for CTEV: Nov 09, 2026
Claritev Corporation Class A Common Stock is expected to report earnings on 11/09/2026 before market open. The report will be for the fiscal Quarter ending Sep 2026. According to Zacks Investment Research, based on 1 analysts' forecasts, the consensus EPS forecast for the quarter is $-3.68. The reported EPS for the same quarter last year was $-4.07.
| Fiscal quarter end | Consensus EPS forecast | High | Low | Estimates |
|---|---|---|---|---|
| Sep 2026 | $-3.68 | $-3.68 | $-3.68 | 1 |
| Dec 2026 | $-3.57 | $-3.57 | $-3.57 | 1 |
| Mar 2027 | $-3.73 | $-3.73 | $-3.73 | 1 |
| Jun 2027 | $-3.56 | $-3.56 | $-3.56 | 1 |
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
Zacks · BNK Invest · The Motley Fool · MarketBeat- Zacks · Oct 29, 6:45 AM EDTOmnicell (OMCL) Q3 Earnings and Revenues Top EstimatesOmnicell (OMCL) delivered earnings and revenue surprises of +38.10% and +1.42%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
- Zacks · Oct 9, 8:51 AM EDTShould You Buy, Hold or Sell Tempus AI Stock Amid AI Boom?TEM's strong data licensing growth, AI-driven innovations and rising shares favor holding the stock, but premium valuation and reimbursement risks warrant caution.
- BNK Invest · Aug 31, 1:57 PM EDTMonday 8/31 Insider Buying Report: CTEV, IPGPAs the saying goes, there are many possible reasons for an insider to sell a stock, but only one reason to buy — they expect to make money. So let's look at two noteworthy recent insider buys. At Claritev, a filing with the SEC revealed that on Friday, CEO & Executive Cha
- The Motley Fool · Aug 14, 9:43 AM EDTClaritev (CTEV) Q2 2026 Earnings Call Transcript@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo
- MarketBeat · Aug 7, 11:03 PM EDTClaritev Q2 Earnings Call HighlightsClaritev (NYSE:CTEV) reported second-quarter revenue growth, record bookings and higher cash flow, prompting the healthcare technology company to raise its full-year revenue, adjusted EBITDA and free-cash-flow outlook. Revenue totaled $257.5 million in the second quarter, up 6.6
- Zacks · Aug 7, 7:10 AM EDTClaritev Corporation (CTEV) Reports Q2 Loss, Tops Revenue EstimatesClaritev Corporation (CTEV) delivered earnings and revenue surprises of +14.88% and +4.60%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
- RTTNews · Aug 7, 5:54 AM EDTClaritev Reports Narrower Loss In Q2, Revenue Up 6.6%; Lifts FY26 Revenue Outlook(RTTNews) – Claritev Corp. (CTEV) Friday announced a narrower loss for the second quarter, as revenue grew 6.6 percent from the prior year. Further, the company raised its revenue and adjusted EBITDA outlook for the full year.
- Zacks · Aug 6, 8:20 AM EDTEvolent Health (EVH) Tops Q2 Earnings and Revenue EstimatesEvolent Health (EVH) delivered earnings and revenue surprises of +300.00% and +6.77%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
- Zacks · Jun 29, 10:52 AM EDTStrength Seen in Evolent Health (EVH): Can Its 9.5% Jump Turn into More Strength?Evolent Health (EVH) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
- Fintel · May 29, 8:04 PM EDTCanaccord Genuity Initiates Coverage of Claritev (CTEV) with Buy RecommendationFintel reports that on May 29, 2026, Canaccord Genuity initiated coverage of Claritev (NYSE:CTEV) with a Buy recommendation. Analyst Price Forecast Suggests 65.29% Upside
- RTTNews · May 20, 10:19 PM EDTSLXN On Track, IMVT Hits New High, CTEV Eyes Blockbuster Revenue, Big Day Ahead For BDTX(RTTNews) – In today's gainers' list, we cover HCW Biologics, its upcoming catalysts and going concern risks; Silexion's development progress of its lead drug candidate SIL204; Immunovant's encouraging rheumatoid arthritis data; why investors will be closely watching Black Diamon
- MarketBeat · May 9, 7:03 PM EDTClaritev Q1 Earnings Call HighlightsClaritev (NYSE:CTEV) reported first-quarter 2026 revenue and adjusted EBITDA ahead of internal expectations, while management said sales momentum and new-market expansion support its full-year outlook. President and CEO Travis Dalton said the quarter reflected “not just performa
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Company profile by TradingView
Financials
Loading fundamental data…
Fundamental data by TradingView
More headlines
More stories for Claritev Corporation from TradingView. Coverage varies.
Loading related news…
Related news by TradingView
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.